Literature DB >> 10532248

Treatment induced changes of bone density and relative risk of vertebral fracture.

S Adami1, O Viapiana, F Corallo.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10532248     DOI： 10.1007/BF03343618

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  31 in total

1.  Bone strength: the bottom line.

Authors:  T A Einhorn
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

Review 2.  Clinical use of bone densitometry.

Authors:  C C Johnston; C W Slemenda; L J Melton
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

Review 3.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

Authors:  B L Riggs; L J Melton; W M O'Fallon
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

4.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

5.  Proximal femur bone mineral levels of US adults.

Authors:  A C Looker; H W Wahner; W L Dunn; M S Calvo; T B Harris; S P Heyse; C C Johnston; R L Lindsay
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

6.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

7.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

8.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.

Authors:  P J Meunier; J L Sebert; J Y Reginster; D Briancon; T Appelboom; P Netter; G Loeb; A Rouillon; S Barry; J C Evreux; B Avouac; X Marchandise
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

10.  Axial and appendicular bone density predict fractures in older women.

Authors:  D M Black; S R Cummings; H K Genant; M C Nevitt; L Palermo; W Browner
Journal:  J Bone Miner Res       Date:  1992-06       Impact factor: 6.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.